標(biāo)題: Titlebook: Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment; Enzo Bonora,Ralph A. DeFronzo Reference work 2018 Spr [打印本頁(yè)] 作者: 召集會(huì)議 時(shí)間: 2025-3-21 19:03
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment影響因子(影響力)
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment影響因子(影響力)學(xué)科排名
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment被引頻次
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment被引頻次學(xué)科排名
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment年度引用
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment年度引用學(xué)科排名
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment讀者反饋
書(shū)目名稱Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment讀者反饋學(xué)科排名
作者: MEET 時(shí)間: 2025-3-21 23:28
Process Management for Knowledge Workod used to diagnose diabetes, diagnostic criteria, and modelling assumptions. This chapter includes a review of the development of the current diagnostic criteria for diabetes and considers classification systems for diabetes.作者: inchoate 時(shí)間: 2025-3-22 02:33 作者: 不愿 時(shí)間: 2025-3-22 08:10 作者: Fortuitous 時(shí)間: 2025-3-22 10:55 作者: FEAT 時(shí)間: 2025-3-22 16:42
https://doi.org/10.1007/978-3-642-45100-3c, immunological, or metabolic markers. These markers can be combined to achieve a higher positive predictive value for T1D and to identify those individuals to be selected for intervention trials..The purpose of this chapter is to set out the epidemiology and the main risk factors which characterizes T1D.作者: FEAT 時(shí)間: 2025-3-22 17:45
Business Process Quality Management the potential to improve diabetes prediction. Multiple diabetes genetic variants have been identified, and the collaborative efforts are made to investigate gene-environment interactions. Continued work to prevent diabetes is warranted through development of precision health interventions and public health strategies targeting these risk factors.作者: 大罵 時(shí)間: 2025-3-23 01:13 作者: 和平主義者 時(shí)間: 2025-3-23 02:41
https://doi.org/10.1007/978-3-030-25759-0 as well as patient’s characteristics. With more clinical data generated, other features of the available oral agents should be taken into account such as durability, predominant effect on fasting vs. postprandial glucose, as well effects beyond their glucose lowering capacity.作者: 感染 時(shí)間: 2025-3-23 08:44 作者: 向宇宙 時(shí)間: 2025-3-23 13:40 作者: commune 時(shí)間: 2025-3-23 14:24
Home Blood Glucose Monitoring and Digital-Health in Diabetes,d with systems that enable personal support for self-monitoring can help make better use of the data available. The chapter includes a brief overview of recent developments with continuous glucose monitoring, flash monitoring and closed loop systems.作者: incubus 時(shí)間: 2025-3-23 20:02
Treatment with Oral Drugs, as well as patient’s characteristics. With more clinical data generated, other features of the available oral agents should be taken into account such as durability, predominant effect on fasting vs. postprandial glucose, as well effects beyond their glucose lowering capacity.作者: 使厭惡 時(shí)間: 2025-3-24 00:38
Methods to Assess In Vivo Insulin Sensitivity and Insulin Secretion,plied in many experimental and observational settings to gauge exact values for each of these two traits. In this chapter, the general principles underlying the assessments of insulin sensitivity and of beta cell function are reviewed, and the most popular tests are described with their pros and cons.作者: nautical 時(shí)間: 2025-3-24 05:43
https://doi.org/10.1007/978-3-030-35020-8sed to identify those with Prediabetes for inclusion in prevention programmes. In this chapter we consider the evidence for screening for both Type 2 Diabetes and Prediabetes, using case studies throughout to highlight issues.作者: ferment 時(shí)間: 2025-3-24 06:42 作者: Genome 時(shí)間: 2025-3-24 12:03 作者: Annotate 時(shí)間: 2025-3-24 16:26
J. Mark Eddy,Julie Poehlmann-Tynanies that can be used to facilitate patient engagement and active participation, prevent acute complications, and ultimately to improve long-term outcomes and quality of life among people with diabetes.作者: 思鄉(xiāng)病 時(shí)間: 2025-3-24 20:15
David Renz,Lonneke Roza,Frans-Joseph Simonsbesity..The present chapter covers how exercise can facilitate optimal glucose control and lipid levels, assist in weight management, and prevent exacerbation of underlying diabetes-complications, moving medicine forward, far beyond the simplistic . of “exercise more.”作者: 時(shí)代 時(shí)間: 2025-3-25 01:36 作者: bleach 時(shí)間: 2025-3-25 05:18 作者: 灰心喪氣 時(shí)間: 2025-3-25 10:04 作者: 妨礙 時(shí)間: 2025-3-25 12:01
Patient Education and Empowerment,ies that can be used to facilitate patient engagement and active participation, prevent acute complications, and ultimately to improve long-term outcomes and quality of life among people with diabetes.作者: hair-bulb 時(shí)間: 2025-3-25 18:24 作者: 功多汁水 時(shí)間: 2025-3-25 22:29 作者: 閃光你我 時(shí)間: 2025-3-26 00:17
Springer International Publishing AG, part of Springer Nature 2018作者: Implicit 時(shí)間: 2025-3-26 06:04 作者: gratify 時(shí)間: 2025-3-26 09:13 作者: jeopardize 時(shí)間: 2025-3-26 14:46 作者: carbohydrate 時(shí)間: 2025-3-26 17:01
Business Process Quality Managemently central obesity, is the strongest risk factor for type 2 diabetes. Diets favoring higher intake of whole grains, green leafy vegetables, and coffee and lower intake of refined grains, red and processed meat, and sugar-sweetened beverages have been associated with a lower risk of type 2 diabetes. 作者: 他日關(guān)稅重重 時(shí)間: 2025-3-26 21:42
Management of Process Excellencetic architecture ranges from highly penetrant monogenetic diseases, such as MODY and neonatal diabetes, to polygenic diseases, such as type 1 and type 2 diabetes that are caused by numerous genetic variants adding up to the individual risk. While both diabetes and diabetic complications have been kn作者: 手銬 時(shí)間: 2025-3-27 02:00 作者: 是剝皮 時(shí)間: 2025-3-27 07:19
Stefan Novotny,Nicholas Rohmannitially noninsulin requiring but with immune markers of type 1 diabetes (T1DM)..The prevalence of LADA has been estimated in a number of multicenter studies of both European and non-European populations. Around 4–14% of patients classified with T2DM have diabetes associated autoantibodies. Among the作者: Mettle 時(shí)間: 2025-3-27 12:59 作者: 鄙視 時(shí)間: 2025-3-27 14:45 作者: 惡意 時(shí)間: 2025-3-27 21:19
https://doi.org/10.1007/978-3-030-35020-8 Prediabetes are increasing and by 2040 it is estimated that there will be 642 million cases of diabetes alone worldwide, with many more people having Prediabetes. Type 2 diabetes can remain undiagnosed for many years and therefore screening can bring forward diagnosis, allowing treatment to be star作者: 最高峰 時(shí)間: 2025-3-28 01:39
Dioxins and Dioxin-like Compounds,ted to affect 592 million by 2035. Monitoring of glucose levels is an?essential component of treatment - providing?feedback to clinician and patient on management?through lifestyle and pharmacotherapy. This chapter provides an overview of the evidence that monitoring levels of glycaemia leads to imp作者: Obloquy 時(shí)間: 2025-3-28 05:55
https://doi.org/10.1007/978-3-030-35020-8macrovascular complications. In diabetes care it is therefore essential to set appropriate glycemic targets (or target ranges) that guide the management of the disease in order to reduce the risk of long-term complications, while avoiding unnecessary burden or adverse events. In this chapter we disc作者: 愉快么 時(shí)間: 2025-3-28 10:15
Joyce A. Arditti,Casey M. McGregorsusceptible individuals, an environmental trigger initiates an immune response. The immune infiltration into pancreatic islets results in beta cell damage, impairment of beta cell function, and potential destruction of beta cells. Consequently, there have been a number of studies using immune interv作者: 倔強(qiáng)一點(diǎn) 時(shí)間: 2025-3-28 13:30 作者: 寵愛(ài) 時(shí)間: 2025-3-28 17:22 作者: innate 時(shí)間: 2025-3-28 20:50
https://doi.org/10.1007/978-3-030-25759-0factors, and morbidity/mortality in diabetic patients..Three main topics are included in this chapter: (1) the effects of dietary treatment on body weight control in diabetic patients; (2) the optimal dietary composition in order to achieve blood glucose control and reduce other cardiovascular risk 作者: 欺騙手段 時(shí)間: 2025-3-29 00:17
David Renz,Lonneke Roza,Frans-Joseph Simonsal metabolic diseases, including diabetes mellitus. The non-pharmacological low-cost nature, along with the health-related benefits, increases the therapeutical . of regular physical activity. In the comprehensive approach of diabetes management, regular physical activity reduces risk of many diseas作者: slow-wave-sleep 時(shí)間: 2025-3-29 05:48
https://doi.org/10.1007/978-3-030-25759-0es. In the meantime, better understanding of the pathophysiology of hyperglycemia in Type 2 diabetes has been gained and the identification of several pathogenitic mechanisms has enabled moving from serendipitous discovery – as for sulfonylureas and metformin – to the development of agents with more作者: Hearten 時(shí)間: 2025-3-29 08:44
Diabetes Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment978-3-319-45015-5Series ISSN 2510-1927 Series E-ISSN 2510-1935 作者: ablate 時(shí)間: 2025-3-29 14:02 作者: Oscillate 時(shí)間: 2025-3-29 15:47 作者: 典型 時(shí)間: 2025-3-29 19:48 作者: florid 時(shí)間: 2025-3-30 02:25
Diagnostic Criteria and Classification,l estimates were published in 2000. Nevertheless, diabetes prevalence estimates are highly dependent on factors such as data sources and quality, method used to diagnose diabetes, diagnostic criteria, and modelling assumptions. This chapter includes a review of the development of the current diagnos作者: 粗鄙的人 時(shí)間: 2025-3-30 04:16
Epidemiology and Risk Factors of Type 1 Diabetes,ta cells in the pancreas. Genetic, epigenetic, metabolic, and environmental factors act together to precipitate the onset of the disease. Clinical T1D represents the end stage of a process resulting from the progressive beta-cell destruction following an asymptomatic period that may last for years. 作者: 完成 時(shí)間: 2025-3-30 11:18
Epidemiology and Risk Factors of Type 2 Diabetes,ly central obesity, is the strongest risk factor for type 2 diabetes. Diets favoring higher intake of whole grains, green leafy vegetables, and coffee and lower intake of refined grains, red and processed meat, and sugar-sweetened beverages have been associated with a lower risk of type 2 diabetes. 作者: 羊欄 時(shí)間: 2025-3-30 15:26 作者: fender 時(shí)間: 2025-3-30 18:07
Pathogenesis of Type 1 Diabetes,beta cells. Much progress has been done in the discovery of disease-predisposing genes, the identification of islet cell autoantigens, and key features of islet autoimmune responses. There is growing evidence for contributing environmental factors, including viruses, the microbiome, and dietary fact作者: 濕潤(rùn) 時(shí)間: 2025-3-31 00:34 作者: 發(fā)起 時(shí)間: 2025-3-31 01:03 作者: 小步走路 時(shí)間: 2025-3-31 08:17 作者: 為寵愛(ài) 時(shí)間: 2025-3-31 12:10
Screening for Diabetes and Prediabetes, Prediabetes are increasing and by 2040 it is estimated that there will be 642 million cases of diabetes alone worldwide, with many more people having Prediabetes. Type 2 diabetes can remain undiagnosed for many years and therefore screening can bring forward diagnosis, allowing treatment to be star作者: Bereavement 時(shí)間: 2025-3-31 16:44
Home Blood Glucose Monitoring and Digital-Health in Diabetes,ted to affect 592 million by 2035. Monitoring of glucose levels is an?essential component of treatment - providing?feedback to clinician and patient on management?through lifestyle and pharmacotherapy. This chapter provides an overview of the evidence that monitoring levels of glycaemia leads to imp作者: POWER 時(shí)間: 2025-3-31 21:11 作者: 乞討 時(shí)間: 2025-3-31 23:17 作者: Glucocorticoids 時(shí)間: 2025-4-1 02:42 作者: CROAK 時(shí)間: 2025-4-1 06:27 作者: Dignant 時(shí)間: 2025-4-1 11:01 作者: NIL 時(shí)間: 2025-4-1 17:18 作者: Insubordinate 時(shí)間: 2025-4-1 20:04 作者: 饒舌的人 時(shí)間: 2025-4-2 02:20
